• Technology and Data
  • Front End Sales and Marketing
  • Allergy
  • HIV
  • Women's Health
  • Migraine
  • Compounding
  • Continuous Glucose Monitoring
  • Mental Health Awareness
  • Veterinary Pharmacy
  • CBD
  • Infectious Disease
  • Eye Health
  • Digestive Health
  • Biosimilars
  • Influenza
  • Shingles
  • COPD Management
  • Pediatrics
  • Generics
  • Pain Management
  • COVID-19
  • Immunization
  • Oncology
  • Anticoagulants
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Respiratory
  • Heart Health
  • Cardiovascular Clinical Consult

Democrats reopen debate on Medicare Part D


The Democrats opened a new salvo in the battle over the Medicare drug benefit with the introduction of the Medicare Prescription Drug Price Negotiation Act of 2007. The bill, which passed the House mostly along party lines, mandates that the Secretary of the Department of Health & Human Services (DHHS) negotiate directly with drug companies over drug prices charged to prescription drug plans (PDPs). Still, the bill's future and how it will impact pharmacy remains unclear.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.